SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
Authors
Keywords
-
Journal
CANCER LETTERS
Volume -, Issue -, Pages 216464
Publisher
Elsevier BV
Online
2023-10-24
DOI
10.1016/j.canlet.2023.216464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer
- (2023) Parminder Kaur et al. CANCER LETTERS
- Current therapy and drug resistance in metastatic castration-resistant prostate cancer
- (2023) Maoping Cai et al. DRUG RESISTANCE UPDATES
- KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis
- (2022) Tanja Limberger et al. Molecular Cancer
- SETD4-mediated KU70 methylation suppresses apoptosis
- (2022) Yuan Wang et al. Cell Reports
- CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
- (2022) Tao Xie et al. Molecular Cancer
- SETD4 cells contribute to brain development and maintain adult stem cell reservoir for neurogenesis
- (2022) Sun-Li Cai et al. Stem Cell Reports
- Embryogenic stem cell-derived intestinal crypt fission directs de novo crypt genesis
- (2022) Xue-Ting Huang et al. Cell Reports
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SETD4-expressing cells contribute to pancreatic development and response to cerulein induced pancreatitis injury
- (2021) Jin-Ze Tian et al. Scientific Reports
- Experimental challenges to modeling prostate cancer heterogeneity
- (2021) Teresita del N.J. Flores-Téllez et al. CANCER LETTERS
- Prostate cancer dormancy and recurrence
- (2021) Frank C. Cackowski et al. CANCER LETTERS
- Non-histone methylation of SET7/9 and its biological functions
- (2021) Lili Gao et al. Recent Patents on Anti-Cancer Drug Discovery
- NUPR1 Silencing Induces Autophagy-Mediated Apoptosis in Multiple Myeloma Cells Through the PI3K/AKT/mTOR Pathway
- (2020) Anmao Li et al. DNA AND CELL BIOLOGY
- The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
- (2020) Boris Y. Shorning et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SET domain-containing protein 4 epigenetically controls breast cancer stem cell quiescence
- (2019) Sen Ye et al. CANCER RESEARCH
- The novel methyltransferase SETD4 regulates TLR agonist-induced expression of cytokines through methylation of lysine 4 at histone 3 in macrophages
- (2019) Yuyun Zhong et al. MOLECULAR IMMUNOLOGY
- Loss of Setd4 delays radiation-induced thymic lymphoma in mice
- (2019) Xing Feng et al. DNA REPAIR
- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
- (2017) Lei Wei et al. EUROPEAN UROLOGY
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- SETD4 Regulates Cell Quiescence and Catalyzes the Trimethylation of H4K20 during Diapause Formation in Artemia
- (2016) Li Dai et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
- (2016) Akash K. Kaushik et al. Nature Communications
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
- (2015) Arndt Katzenwadel et al. CANCER LETTERS
- Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity
- (2013) S. Jorgensen et al. NUCLEIC ACIDS RESEARCH
- Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance
- (2012) Andrew J. Vincent et al. FEBS LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
- (2009) Li-Ru He et al. BMC CANCER
- Emerging role of nuclear protein 1 (NUPR1) in cancer biology
- (2009) Uttio Roy Chowdhury et al. CANCER AND METASTASIS REVIEWS
- DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells
- (2008) D. J. Steger et al. MOLECULAR AND CELLULAR BIOLOGY
- Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
- (2008) Yongkun Wei et al. MOLECULAR CARCINOGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More